Commission facility to monitor CEE (Central and Eastern Europe) directive transpositions..
This article was originally published in Clinica
Executive Summary
Progress on the transposition of the medical devices directives in the 10 countries due to become members of the EU in May 2004 can now be quickly checked and monitored. This is thanks to a feature contained in a new website constructed by Directorate General Enterprise (DGE), the European Commission service responsible for the regulation of medical devices.
You may also be interested in...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.